Trial Profile
Open Label, Single Center, Pilot Study of the Use of BOTOX Injections, Sensorcaine Injections and Progressive Dilation Under Anesthesia for the Treatment of Primary Vaginismus.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Bupivacaine
- Indications Vaginal diseases
- Focus Therapeutic Use
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2011 Planned end date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 17 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.